nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—AOX1—Methotrexate—stomach cancer	0.196	0.481	CbGbCtD
Raloxifene—CYP2B6—Irinotecan—stomach cancer	0.0713	0.175	CbGbCtD
Raloxifene—CYP2C8—Fluorouracil—stomach cancer	0.0518	0.127	CbGbCtD
Raloxifene—CYP2B6—Doxorubicin—stomach cancer	0.0389	0.0953	CbGbCtD
Raloxifene—CYP3A4—Irinotecan—stomach cancer	0.0219	0.0536	CbGbCtD
Raloxifene—CYP3A4—Docetaxel—stomach cancer	0.016	0.0393	CbGbCtD
Raloxifene—CYP3A4—Doxorubicin—stomach cancer	0.012	0.0293	CbGbCtD
Raloxifene—AOX1—gall bladder—stomach cancer	0.00494	0.0594	CbGeAlD
Raloxifene—EBP—endocrine gland—stomach cancer	0.0048	0.0577	CbGeAlD
Raloxifene—EBP—liver—stomach cancer	0.00432	0.052	CbGeAlD
Raloxifene—ESR1—blood vessel—stomach cancer	0.00374	0.045	CbGeAlD
Raloxifene—ESR2—hematopoietic system—stomach cancer	0.00291	0.035	CbGeAlD
Raloxifene—ESR2—epithelium—stomach cancer	0.00266	0.032	CbGeAlD
Raloxifene—ESR2—smooth muscle tissue—stomach cancer	0.00256	0.0308	CbGeAlD
Raloxifene—CYP19A1—hematopoietic system—stomach cancer	0.00229	0.0275	CbGeAlD
Raloxifene—AOX1—pancreas—stomach cancer	0.00228	0.0274	CbGeAlD
Raloxifene—ESR2—lymphoid tissue—stomach cancer	0.00205	0.0246	CbGeAlD
Raloxifene—ESR2—digestive system—stomach cancer	0.00202	0.0243	CbGeAlD
Raloxifene—ESR1—hematopoietic system—stomach cancer	0.00199	0.0239	CbGeAlD
Raloxifene—SIGMAR1—smooth muscle tissue—stomach cancer	0.00198	0.0239	CbGeAlD
Raloxifene—HTR2B—smooth muscle tissue—stomach cancer	0.00198	0.0238	CbGeAlD
Raloxifene—AOX1—digestive system—stomach cancer	0.00195	0.0234	CbGeAlD
Raloxifene—SIGMAR1—pancreas—stomach cancer	0.00183	0.0221	CbGeAlD
Raloxifene—ESR1—epithelium—stomach cancer	0.00182	0.0219	CbGeAlD
Raloxifene—ESR1—smooth muscle tissue—stomach cancer	0.00175	0.0211	CbGeAlD
Raloxifene—ESR2—endocrine gland—stomach cancer	0.00167	0.0201	CbGeAlD
Raloxifene—CYP2C8—hematopoietic system—stomach cancer	0.00164	0.0197	CbGeAlD
Raloxifene—AOX1—endocrine gland—stomach cancer	0.00161	0.0193	CbGeAlD
Raloxifene—HTR2B—digestive system—stomach cancer	0.00156	0.0188	CbGeAlD
Raloxifene—ESR2—liver—stomach cancer	0.00151	0.0181	CbGeAlD
Raloxifene—CYP2B6—hematopoietic system—stomach cancer	0.00147	0.0177	CbGeAlD
Raloxifene—AOX1—liver—stomach cancer	0.00145	0.0174	CbGeAlD
Raloxifene—SIGMAR1—bone marrow—stomach cancer	0.00144	0.0174	CbGeAlD
Raloxifene—ESR1—lymphoid tissue—stomach cancer	0.0014	0.0169	CbGeAlD
Raloxifene—ESR1—digestive system—stomach cancer	0.00138	0.0166	CbGeAlD
Raloxifene—CYP19A1—endocrine gland—stomach cancer	0.00132	0.0158	CbGeAlD
Raloxifene—CYP19A1—liver—stomach cancer	0.00119	0.0143	CbGeAlD
Raloxifene—SIGMAR1—liver—stomach cancer	0.00117	0.014	CbGeAlD
Raloxifene—ESR2—lymph node—stomach cancer	0.00115	0.0139	CbGeAlD
Raloxifene—ESR1—endocrine gland—stomach cancer	0.00114	0.0138	CbGeAlD
Raloxifene—AOX1—lymph node—stomach cancer	0.00111	0.0134	CbGeAlD
Raloxifene—CYP3A4—hematopoietic system—stomach cancer	0.00111	0.0134	CbGeAlD
Raloxifene—CYP2B6—lymphoid tissue—stomach cancer	0.00104	0.0125	CbGeAlD
Raloxifene—ESR1—liver—stomach cancer	0.00103	0.0124	CbGeAlD
Raloxifene—CYP2B6—digestive system—stomach cancer	0.00102	0.0123	CbGeAlD
Raloxifene—CYP2C8—endocrine gland—stomach cancer	0.000942	0.0113	CbGeAlD
Raloxifene—CYP19A1—lymph node—stomach cancer	0.00091	0.0109	CbGeAlD
Raloxifene—SIGMAR1—lymph node—stomach cancer	0.000894	0.0108	CbGeAlD
Raloxifene—HTR2B—lymph node—stomach cancer	0.000892	0.0107	CbGeAlD
Raloxifene—CYP2C8—liver—stomach cancer	0.000849	0.0102	CbGeAlD
Raloxifene—CYP2B6—endocrine gland—stomach cancer	0.000845	0.0102	CbGeAlD
Raloxifene—ESR1—lymph node—stomach cancer	0.000791	0.00951	CbGeAlD
Raloxifene—CYP3A4—digestive system—stomach cancer	0.000772	0.00929	CbGeAlD
Raloxifene—CYP2B6—liver—stomach cancer	0.000762	0.00916	CbGeAlD
Raloxifene—CYP3A4—endocrine gland—stomach cancer	0.000638	0.00768	CbGeAlD
Raloxifene—CYP3A4—liver—stomach cancer	0.000575	0.00692	CbGeAlD
Raloxifene—Pharyngitis—Docetaxel—stomach cancer	0.000555	0.0019	CcSEcCtD
Raloxifene—Urinary tract disorder—Docetaxel—stomach cancer	0.000552	0.00189	CcSEcCtD
Raloxifene—Oedema peripheral—Docetaxel—stomach cancer	0.000551	0.00189	CcSEcCtD
Raloxifene—Connective tissue disorder—Docetaxel—stomach cancer	0.000549	0.00188	CcSEcCtD
Raloxifene—Urethral disorder—Docetaxel—stomach cancer	0.000548	0.00188	CcSEcCtD
Raloxifene—Infection—Fluorouracil—stomach cancer	0.000546	0.00187	CcSEcCtD
Raloxifene—Rhinitis—Capecitabine—stomach cancer	0.000542	0.00186	CcSEcCtD
Raloxifene—Nervous system disorder—Fluorouracil—stomach cancer	0.000539	0.00185	CcSEcCtD
Raloxifene—Hot flush—Doxorubicin—stomach cancer	0.000539	0.00185	CcSEcCtD
Raloxifene—Thrombocytopenia—Fluorouracil—stomach cancer	0.000539	0.00185	CcSEcCtD
Raloxifene—Hypoaesthesia—Capecitabine—stomach cancer	0.000538	0.00185	CcSEcCtD
Raloxifene—Pharyngitis—Capecitabine—stomach cancer	0.000537	0.00184	CcSEcCtD
Raloxifene—Migraine—Epirubicin—stomach cancer	0.000536	0.00184	CcSEcCtD
Raloxifene—Urinary tract disorder—Capecitabine—stomach cancer	0.000534	0.00183	CcSEcCtD
Raloxifene—Menopausal symptoms—Doxorubicin—stomach cancer	0.000534	0.00183	CcSEcCtD
Raloxifene—Oedema peripheral—Capecitabine—stomach cancer	0.000533	0.00183	CcSEcCtD
Raloxifene—Connective tissue disorder—Capecitabine—stomach cancer	0.000532	0.00182	CcSEcCtD
Raloxifene—Urethral disorder—Capecitabine—stomach cancer	0.00053	0.00182	CcSEcCtD
Raloxifene—Breast disorder—Methotrexate—stomach cancer	0.000526	0.0018	CcSEcCtD
Raloxifene—Insomnia—Irinotecan—stomach cancer	0.000519	0.00178	CcSEcCtD
Raloxifene—Flushing—Docetaxel—stomach cancer	0.000519	0.00178	CcSEcCtD
Raloxifene—Cardiac disorder—Docetaxel—stomach cancer	0.000519	0.00178	CcSEcCtD
Raloxifene—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000514	0.00176	CcSEcCtD
Raloxifene—Angiopathy—Docetaxel—stomach cancer	0.000507	0.00174	CcSEcCtD
Raloxifene—Dyspepsia—Irinotecan—stomach cancer	0.000506	0.00173	CcSEcCtD
Raloxifene—Cardiac disorder—Capecitabine—stomach cancer	0.000502	0.00172	CcSEcCtD
Raloxifene—Flushing—Capecitabine—stomach cancer	0.000502	0.00172	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000501	0.00172	CcSEcCtD
Raloxifene—Insomnia—Fluorouracil—stomach cancer	0.000498	0.00171	CcSEcCtD
Raloxifene—Migraine—Doxorubicin—stomach cancer	0.000496	0.0017	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000496	0.0017	CcSEcCtD
Raloxifene—Breast disorder—Epirubicin—stomach cancer	0.000492	0.00169	CcSEcCtD
Raloxifene—Pain—Irinotecan—stomach cancer	0.000491	0.00168	CcSEcCtD
Raloxifene—Angiopathy—Capecitabine—stomach cancer	0.000491	0.00168	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000491	0.00168	CcSEcCtD
Raloxifene—Dyspepsia—Fluorouracil—stomach cancer	0.000484	0.00166	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000475	0.00163	CcSEcCtD
Raloxifene—Influenza—Epirubicin—stomach cancer	0.000471	0.00162	CcSEcCtD
Raloxifene—Pain—Fluorouracil—stomach cancer	0.00047	0.00161	CcSEcCtD
Raloxifene—Gastrointestinal pain—Irinotecan—stomach cancer	0.00047	0.00161	CcSEcCtD
Raloxifene—Muscle spasms—Docetaxel—stomach cancer	0.000468	0.0016	CcSEcCtD
Raloxifene—Flatulence—Capecitabine—stomach cancer	0.000464	0.00159	CcSEcCtD
Raloxifene—Breast disorder—Doxorubicin—stomach cancer	0.000456	0.00156	CcSEcCtD
Raloxifene—Abdominal pain—Irinotecan—stomach cancer	0.000454	0.00156	CcSEcCtD
Raloxifene—Body temperature increased—Irinotecan—stomach cancer	0.000454	0.00156	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000454	0.00156	CcSEcCtD
Raloxifene—Bronchitis—Epirubicin—stomach cancer	0.000453	0.00155	CcSEcCtD
Raloxifene—Muscle spasms—Capecitabine—stomach cancer	0.000453	0.00155	CcSEcCtD
Raloxifene—Pneumonia—Methotrexate—stomach cancer	0.000451	0.00155	CcSEcCtD
Raloxifene—Depression—Methotrexate—stomach cancer	0.000447	0.00153	CcSEcCtD
Raloxifene—Syncope—Docetaxel—stomach cancer	0.000436	0.0015	CcSEcCtD
Raloxifene—Conjunctivitis—Methotrexate—stomach cancer	0.000436	0.0015	CcSEcCtD
Raloxifene—Influenza—Doxorubicin—stomach cancer	0.000436	0.00149	CcSEcCtD
Raloxifene—Body temperature increased—Fluorouracil—stomach cancer	0.000435	0.00149	CcSEcCtD
Raloxifene—Sweating—Methotrexate—stomach cancer	0.00043	0.00148	CcSEcCtD
Raloxifene—Weight increased—Epirubicin—stomach cancer	0.000429	0.00147	CcSEcCtD
Raloxifene—Loss of consciousness—Docetaxel—stomach cancer	0.000428	0.00147	CcSEcCtD
Raloxifene—Cough—Docetaxel—stomach cancer	0.000425	0.00146	CcSEcCtD
Raloxifene—Vertigo—Capecitabine—stomach cancer	0.000423	0.00145	CcSEcCtD
Raloxifene—Syncope—Capecitabine—stomach cancer	0.000422	0.00145	CcSEcCtD
Raloxifene—Pneumonia—Epirubicin—stomach cancer	0.000422	0.00145	CcSEcCtD
Raloxifene—Bronchitis—Doxorubicin—stomach cancer	0.000419	0.00144	CcSEcCtD
Raloxifene—Chest pain—Docetaxel—stomach cancer	0.000414	0.00142	CcSEcCtD
Raloxifene—Arthralgia—Docetaxel—stomach cancer	0.000414	0.00142	CcSEcCtD
Raloxifene—Myalgia—Docetaxel—stomach cancer	0.000414	0.00142	CcSEcCtD
Raloxifene—Loss of consciousness—Capecitabine—stomach cancer	0.000414	0.00142	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000411	0.00141	CcSEcCtD
Raloxifene—Cough—Capecitabine—stomach cancer	0.000411	0.00141	CcSEcCtD
Raloxifene—Urinary tract infection—Epirubicin—stomach cancer	0.000408	0.0014	CcSEcCtD
Raloxifene—Conjunctivitis—Epirubicin—stomach cancer	0.000408	0.0014	CcSEcCtD
Raloxifene—Sweating—Epirubicin—stomach cancer	0.000403	0.00138	CcSEcCtD
Raloxifene—Chest pain—Capecitabine—stomach cancer	0.000401	0.00138	CcSEcCtD
Raloxifene—Arthralgia—Capecitabine—stomach cancer	0.000401	0.00138	CcSEcCtD
Raloxifene—Myalgia—Capecitabine—stomach cancer	0.000401	0.00138	CcSEcCtD
Raloxifene—Pharyngitis—Methotrexate—stomach cancer	0.0004	0.00137	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000398	0.00137	CcSEcCtD
Raloxifene—Urinary tract disorder—Methotrexate—stomach cancer	0.000398	0.00136	CcSEcCtD
Raloxifene—Weight increased—Doxorubicin—stomach cancer	0.000397	0.00136	CcSEcCtD
Raloxifene—Urethral disorder—Methotrexate—stomach cancer	0.000395	0.00135	CcSEcCtD
Raloxifene—Infection—Docetaxel—stomach cancer	0.000394	0.00135	CcSEcCtD
Raloxifene—Sinusitis—Epirubicin—stomach cancer	0.000394	0.00135	CcSEcCtD
Raloxifene—Diarrhoea—Irinotecan—stomach cancer	0.000393	0.00135	CcSEcCtD
Raloxifene—Pneumonia—Doxorubicin—stomach cancer	0.000391	0.00134	CcSEcCtD
Raloxifene—Shock—Docetaxel—stomach cancer	0.000391	0.00134	CcSEcCtD
Raloxifene—Nervous system disorder—Docetaxel—stomach cancer	0.000389	0.00134	CcSEcCtD
Raloxifene—Thrombocytopenia—Docetaxel—stomach cancer	0.000389	0.00133	CcSEcCtD
Raloxifene—Skin disorder—Docetaxel—stomach cancer	0.000386	0.00132	CcSEcCtD
Raloxifene—Infection—Capecitabine—stomach cancer	0.000382	0.00131	CcSEcCtD
Raloxifene—Dizziness—Irinotecan—stomach cancer	0.00038	0.0013	CcSEcCtD
Raloxifene—Shock—Capecitabine—stomach cancer	0.000378	0.0013	CcSEcCtD
Raloxifene—Rhinitis—Epirubicin—stomach cancer	0.000378	0.0013	CcSEcCtD
Raloxifene—Conjunctivitis—Doxorubicin—stomach cancer	0.000378	0.0013	CcSEcCtD
Raloxifene—Urinary tract infection—Doxorubicin—stomach cancer	0.000378	0.0013	CcSEcCtD
Raloxifene—Nervous system disorder—Capecitabine—stomach cancer	0.000377	0.00129	CcSEcCtD
Raloxifene—Diarrhoea—Fluorouracil—stomach cancer	0.000376	0.00129	CcSEcCtD
Raloxifene—Thrombocytopenia—Capecitabine—stomach cancer	0.000376	0.00129	CcSEcCtD
Raloxifene—Hypoaesthesia—Epirubicin—stomach cancer	0.000375	0.00129	CcSEcCtD
Raloxifene—Pharyngitis—Epirubicin—stomach cancer	0.000374	0.00128	CcSEcCtD
Raloxifene—Cardiac disorder—Methotrexate—stomach cancer	0.000374	0.00128	CcSEcCtD
Raloxifene—Skin disorder—Capecitabine—stomach cancer	0.000373	0.00128	CcSEcCtD
Raloxifene—Sweating—Doxorubicin—stomach cancer	0.000372	0.00128	CcSEcCtD
Raloxifene—Urinary tract disorder—Epirubicin—stomach cancer	0.000372	0.00128	CcSEcCtD
Raloxifene—Hyperhidrosis—Capecitabine—stomach cancer	0.000372	0.00127	CcSEcCtD
Raloxifene—Oedema peripheral—Epirubicin—stomach cancer	0.000371	0.00127	CcSEcCtD
Raloxifene—Connective tissue disorder—Epirubicin—stomach cancer	0.00037	0.00127	CcSEcCtD
Raloxifene—Urethral disorder—Epirubicin—stomach cancer	0.000369	0.00127	CcSEcCtD
Raloxifene—Angiopathy—Methotrexate—stomach cancer	0.000365	0.00125	CcSEcCtD
Raloxifene—Vomiting—Irinotecan—stomach cancer	0.000365	0.00125	CcSEcCtD
Raloxifene—Sinusitis—Doxorubicin—stomach cancer	0.000364	0.00125	CcSEcCtD
Raloxifene—Dizziness—Fluorouracil—stomach cancer	0.000364	0.00125	CcSEcCtD
Raloxifene—Rash—Irinotecan—stomach cancer	0.000362	0.00124	CcSEcCtD
Raloxifene—Dermatitis—Irinotecan—stomach cancer	0.000362	0.00124	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000362	0.00124	CcSEcCtD
Raloxifene—Headache—Irinotecan—stomach cancer	0.00036	0.00123	CcSEcCtD
Raloxifene—Insomnia—Docetaxel—stomach cancer	0.000359	0.00123	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00035	0.0012	CcSEcCtD
Raloxifene—Cardiac disorder—Epirubicin—stomach cancer	0.00035	0.0012	CcSEcCtD
Raloxifene—Flushing—Epirubicin—stomach cancer	0.00035	0.0012	CcSEcCtD
Raloxifene—Vomiting—Fluorouracil—stomach cancer	0.00035	0.0012	CcSEcCtD
Raloxifene—Rhinitis—Doxorubicin—stomach cancer	0.00035	0.0012	CcSEcCtD
Raloxifene—Dyspepsia—Docetaxel—stomach cancer	0.000349	0.0012	CcSEcCtD
Raloxifene—Insomnia—Capecitabine—stomach cancer	0.000348	0.00119	CcSEcCtD
Raloxifene—Hypoaesthesia—Doxorubicin—stomach cancer	0.000347	0.00119	CcSEcCtD
Raloxifene—Rash—Fluorouracil—stomach cancer	0.000347	0.00119	CcSEcCtD
Raloxifene—Dermatitis—Fluorouracil—stomach cancer	0.000347	0.00119	CcSEcCtD
Raloxifene—Pharyngitis—Doxorubicin—stomach cancer	0.000346	0.00119	CcSEcCtD
Raloxifene—Headache—Fluorouracil—stomach cancer	0.000345	0.00118	CcSEcCtD
Raloxifene—Urinary tract disorder—Doxorubicin—stomach cancer	0.000344	0.00118	CcSEcCtD
Raloxifene—Oedema peripheral—Doxorubicin—stomach cancer	0.000344	0.00118	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000343	0.00118	CcSEcCtD
Raloxifene—Connective tissue disorder—Doxorubicin—stomach cancer	0.000343	0.00118	CcSEcCtD
Raloxifene—Angiopathy—Epirubicin—stomach cancer	0.000342	0.00117	CcSEcCtD
Raloxifene—Urethral disorder—Doxorubicin—stomach cancer	0.000342	0.00117	CcSEcCtD
Raloxifene—Nausea—Irinotecan—stomach cancer	0.000341	0.00117	CcSEcCtD
Raloxifene—Pain—Docetaxel—stomach cancer	0.00034	0.00116	CcSEcCtD
Raloxifene—Dyspepsia—Capecitabine—stomach cancer	0.000338	0.00116	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000332	0.00114	CcSEcCtD
Raloxifene—Pain—Capecitabine—stomach cancer	0.000329	0.00113	CcSEcCtD
Raloxifene—Nausea—Fluorouracil—stomach cancer	0.000327	0.00112	CcSEcCtD
Raloxifene—Gastrointestinal pain—Docetaxel—stomach cancer	0.000325	0.00111	CcSEcCtD
Raloxifene—Flushing—Doxorubicin—stomach cancer	0.000324	0.00111	CcSEcCtD
Raloxifene—Cardiac disorder—Doxorubicin—stomach cancer	0.000324	0.00111	CcSEcCtD
Raloxifene—Flatulence—Epirubicin—stomach cancer	0.000323	0.00111	CcSEcCtD
Raloxifene—Angiopathy—Doxorubicin—stomach cancer	0.000316	0.00109	CcSEcCtD
Raloxifene—Muscle spasms—Epirubicin—stomach cancer	0.000315	0.00108	CcSEcCtD
Raloxifene—Vertigo—Methotrexate—stomach cancer	0.000315	0.00108	CcSEcCtD
Raloxifene—Gastrointestinal pain—Capecitabine—stomach cancer	0.000314	0.00108	CcSEcCtD
Raloxifene—Body temperature increased—Docetaxel—stomach cancer	0.000314	0.00108	CcSEcCtD
Raloxifene—Abdominal pain—Docetaxel—stomach cancer	0.000314	0.00108	CcSEcCtD
Raloxifene—Cough—Methotrexate—stomach cancer	0.000306	0.00105	CcSEcCtD
Raloxifene—Abdominal pain—Capecitabine—stomach cancer	0.000304	0.00104	CcSEcCtD
Raloxifene—Body temperature increased—Capecitabine—stomach cancer	0.000304	0.00104	CcSEcCtD
Raloxifene—Flatulence—Doxorubicin—stomach cancer	0.000299	0.00103	CcSEcCtD
Raloxifene—Chest pain—Methotrexate—stomach cancer	0.000299	0.00102	CcSEcCtD
Raloxifene—Arthralgia—Methotrexate—stomach cancer	0.000299	0.00102	CcSEcCtD
Raloxifene—Myalgia—Methotrexate—stomach cancer	0.000299	0.00102	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000296	0.00102	CcSEcCtD
Raloxifene—Vertigo—Epirubicin—stomach cancer	0.000295	0.00101	CcSEcCtD
Raloxifene—Syncope—Epirubicin—stomach cancer	0.000294	0.00101	CcSEcCtD
Raloxifene—Muscle spasms—Doxorubicin—stomach cancer	0.000292	0.001	CcSEcCtD
Raloxifene—Loss of consciousness—Epirubicin—stomach cancer	0.000288	0.000989	CcSEcCtD
Raloxifene—Cough—Epirubicin—stomach cancer	0.000286	0.000982	CcSEcCtD
Raloxifene—Infection—Methotrexate—stomach cancer	0.000284	0.000975	CcSEcCtD
Raloxifene—Nervous system disorder—Methotrexate—stomach cancer	0.000281	0.000962	CcSEcCtD
Raloxifene—Thrombocytopenia—Methotrexate—stomach cancer	0.00028	0.000961	CcSEcCtD
Raloxifene—Chest pain—Epirubicin—stomach cancer	0.000279	0.000958	CcSEcCtD
Raloxifene—Arthralgia—Epirubicin—stomach cancer	0.000279	0.000958	CcSEcCtD
Raloxifene—Myalgia—Epirubicin—stomach cancer	0.000279	0.000958	CcSEcCtD
Raloxifene—Skin disorder—Methotrexate—stomach cancer	0.000278	0.000953	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000277	0.000952	CcSEcCtD
Raloxifene—Hyperhidrosis—Methotrexate—stomach cancer	0.000277	0.000949	CcSEcCtD
Raloxifene—Vertigo—Doxorubicin—stomach cancer	0.000273	0.000936	CcSEcCtD
Raloxifene—Syncope—Doxorubicin—stomach cancer	0.000272	0.000934	CcSEcCtD
Raloxifene—Diarrhoea—Docetaxel—stomach cancer	0.000272	0.000932	CcSEcCtD
Raloxifene—Loss of consciousness—Doxorubicin—stomach cancer	0.000267	0.000915	CcSEcCtD
Raloxifene—Infection—Epirubicin—stomach cancer	0.000266	0.000912	CcSEcCtD
Raloxifene—Cough—Doxorubicin—stomach cancer	0.000265	0.000909	CcSEcCtD
Raloxifene—Shock—Epirubicin—stomach cancer	0.000263	0.000904	CcSEcCtD
Raloxifene—Diarrhoea—Capecitabine—stomach cancer	0.000263	0.000902	CcSEcCtD
Raloxifene—Nervous system disorder—Epirubicin—stomach cancer	0.000263	0.000901	CcSEcCtD
Raloxifene—Dizziness—Docetaxel—stomach cancer	0.000263	0.0009	CcSEcCtD
Raloxifene—Thrombocytopenia—Epirubicin—stomach cancer	0.000262	0.000899	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000261	0.000894	CcSEcCtD
Raloxifene—Skin disorder—Epirubicin—stomach cancer	0.00026	0.000892	CcSEcCtD
Raloxifene—Hyperhidrosis—Epirubicin—stomach cancer	0.000259	0.000888	CcSEcCtD
Raloxifene—Insomnia—Methotrexate—stomach cancer	0.000259	0.000888	CcSEcCtD
Raloxifene—Arthralgia—Doxorubicin—stomach cancer	0.000258	0.000887	CcSEcCtD
Raloxifene—Chest pain—Doxorubicin—stomach cancer	0.000258	0.000887	CcSEcCtD
Raloxifene—Myalgia—Doxorubicin—stomach cancer	0.000258	0.000887	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000257	0.00088	CcSEcCtD
Raloxifene—Dizziness—Capecitabine—stomach cancer	0.000254	0.000872	CcSEcCtD
Raloxifene—Vomiting—Docetaxel—stomach cancer	0.000252	0.000866	CcSEcCtD
Raloxifene—Dyspepsia—Methotrexate—stomach cancer	0.000252	0.000864	CcSEcCtD
Raloxifene—Rash—Docetaxel—stomach cancer	0.00025	0.000859	CcSEcCtD
Raloxifene—Dermatitis—Docetaxel—stomach cancer	0.00025	0.000858	CcSEcCtD
Raloxifene—Headache—Docetaxel—stomach cancer	0.000249	0.000853	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000247	0.000847	CcSEcCtD
Raloxifene—Infection—Doxorubicin—stomach cancer	0.000246	0.000844	CcSEcCtD
Raloxifene—Pain—Methotrexate—stomach cancer	0.000245	0.000839	CcSEcCtD
Raloxifene—Vomiting—Capecitabine—stomach cancer	0.000244	0.000838	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000244	0.000837	CcSEcCtD
Raloxifene—Shock—Doxorubicin—stomach cancer	0.000244	0.000836	CcSEcCtD
Raloxifene—Nervous system disorder—Doxorubicin—stomach cancer	0.000243	0.000833	CcSEcCtD
Raloxifene—Thrombocytopenia—Doxorubicin—stomach cancer	0.000243	0.000832	CcSEcCtD
Raloxifene—Rash—Capecitabine—stomach cancer	0.000242	0.000831	CcSEcCtD
Raloxifene—Insomnia—Epirubicin—stomach cancer	0.000242	0.000831	CcSEcCtD
Raloxifene—Dermatitis—Capecitabine—stomach cancer	0.000242	0.000831	CcSEcCtD
Raloxifene—Headache—Capecitabine—stomach cancer	0.000241	0.000826	CcSEcCtD
Raloxifene—Skin disorder—Doxorubicin—stomach cancer	0.000241	0.000825	CcSEcCtD
Raloxifene—Hyperhidrosis—Doxorubicin—stomach cancer	0.00024	0.000822	CcSEcCtD
Raloxifene—Nausea—Docetaxel—stomach cancer	0.000236	0.000809	CcSEcCtD
Raloxifene—Dyspepsia—Epirubicin—stomach cancer	0.000236	0.000809	CcSEcCtD
Raloxifene—Gastrointestinal pain—Methotrexate—stomach cancer	0.000234	0.000803	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000231	0.000793	CcSEcCtD
Raloxifene—Pain—Epirubicin—stomach cancer	0.000229	0.000785	CcSEcCtD
Raloxifene—Nausea—Capecitabine—stomach cancer	0.000228	0.000783	CcSEcCtD
Raloxifene—Abdominal pain—Methotrexate—stomach cancer	0.000226	0.000776	CcSEcCtD
Raloxifene—Body temperature increased—Methotrexate—stomach cancer	0.000226	0.000776	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000226	0.000774	CcSEcCtD
Raloxifene—Insomnia—Doxorubicin—stomach cancer	0.000224	0.000769	CcSEcCtD
Raloxifene—Gastrointestinal pain—Epirubicin—stomach cancer	0.000219	0.000751	CcSEcCtD
Raloxifene—Dyspepsia—Doxorubicin—stomach cancer	0.000218	0.000748	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000214	0.000734	CcSEcCtD
Raloxifene—Pain—Doxorubicin—stomach cancer	0.000212	0.000727	CcSEcCtD
Raloxifene—Abdominal pain—Epirubicin—stomach cancer	0.000212	0.000726	CcSEcCtD
Raloxifene—Body temperature increased—Epirubicin—stomach cancer	0.000212	0.000726	CcSEcCtD
Raloxifene—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000203	0.000695	CcSEcCtD
Raloxifene—Body temperature increased—Doxorubicin—stomach cancer	0.000196	0.000672	CcSEcCtD
Raloxifene—Abdominal pain—Doxorubicin—stomach cancer	0.000196	0.000672	CcSEcCtD
Raloxifene—Diarrhoea—Methotrexate—stomach cancer	0.000196	0.000672	CcSEcCtD
Raloxifene—Dizziness—Methotrexate—stomach cancer	0.000189	0.000649	CcSEcCtD
Raloxifene—Diarrhoea—Epirubicin—stomach cancer	0.000183	0.000628	CcSEcCtD
Raloxifene—Vomiting—Methotrexate—stomach cancer	0.000182	0.000624	CcSEcCtD
Raloxifene—Rash—Methotrexate—stomach cancer	0.00018	0.000619	CcSEcCtD
Raloxifene—Dermatitis—Methotrexate—stomach cancer	0.00018	0.000618	CcSEcCtD
Raloxifene—Headache—Methotrexate—stomach cancer	0.000179	0.000615	CcSEcCtD
Raloxifene—Dizziness—Epirubicin—stomach cancer	0.000177	0.000607	CcSEcCtD
Raloxifene—Vomiting—Epirubicin—stomach cancer	0.00017	0.000584	CcSEcCtD
Raloxifene—Nausea—Methotrexate—stomach cancer	0.00017	0.000583	CcSEcCtD
Raloxifene—Diarrhoea—Doxorubicin—stomach cancer	0.00017	0.000581	CcSEcCtD
Raloxifene—Rash—Epirubicin—stomach cancer	0.000169	0.000579	CcSEcCtD
Raloxifene—Dermatitis—Epirubicin—stomach cancer	0.000169	0.000579	CcSEcCtD
Raloxifene—Headache—Epirubicin—stomach cancer	0.000168	0.000575	CcSEcCtD
Raloxifene—Dizziness—Doxorubicin—stomach cancer	0.000164	0.000562	CcSEcCtD
Raloxifene—Nausea—Epirubicin—stomach cancer	0.000159	0.000546	CcSEcCtD
Raloxifene—Vomiting—Doxorubicin—stomach cancer	0.000158	0.00054	CcSEcCtD
Raloxifene—Rash—Doxorubicin—stomach cancer	0.000156	0.000536	CcSEcCtD
Raloxifene—Dermatitis—Doxorubicin—stomach cancer	0.000156	0.000535	CcSEcCtD
Raloxifene—Headache—Doxorubicin—stomach cancer	0.000155	0.000532	CcSEcCtD
Raloxifene—Nausea—Doxorubicin—stomach cancer	0.000147	0.000505	CcSEcCtD
Raloxifene—AOX1—Metabolism—PTGS2—stomach cancer	2.81e-05	0.000129	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTP1—stomach cancer	2.8e-05	0.000129	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—ERCC2—stomach cancer	2.79e-05	0.000129	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ANXA1—stomach cancer	2.78e-05	0.000128	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PGLS—stomach cancer	2.78e-05	0.000128	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BLVRB—stomach cancer	2.78e-05	0.000128	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—HMOX1—stomach cancer	2.77e-05	0.000127	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALDOB—stomach cancer	2.72e-05	0.000125	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6R—stomach cancer	2.7e-05	0.000125	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRB1—stomach cancer	2.7e-05	0.000124	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—RHOA—stomach cancer	2.69e-05	0.000124	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—RHOA—stomach cancer	2.67e-05	0.000123	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.65e-05	0.000122	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADRB2—stomach cancer	2.62e-05	0.000121	CbGpPWpGaD
Raloxifene—AOX1—Disease—STAT3—stomach cancer	2.62e-05	0.000121	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SMAD4—stomach cancer	2.61e-05	0.00012	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TYMS—stomach cancer	2.61e-05	0.00012	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTT1—stomach cancer	2.6e-05	0.00012	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCL8—stomach cancer	2.59e-05	0.000119	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTM1—stomach cancer	2.58e-05	0.000119	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RPS6—stomach cancer	2.58e-05	0.000119	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PPP2R1A—stomach cancer	2.57e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP2A6—stomach cancer	2.57e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.56e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.56e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALOX5—stomach cancer	2.53e-05	0.000117	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—stomach cancer	2.52e-05	0.000116	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAPK3—stomach cancer	2.5e-05	0.000115	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKR1C3—stomach cancer	2.5e-05	0.000115	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—DPYD—stomach cancer	2.49e-05	0.000115	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FYN—stomach cancer	2.48e-05	0.000114	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MAPK3—stomach cancer	2.47e-05	0.000114	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—RHOA—stomach cancer	2.44e-05	0.000113	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ENO1—stomach cancer	2.43e-05	0.000112	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—stomach cancer	2.43e-05	0.000112	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ERCC2—stomach cancer	2.42e-05	0.000112	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—stomach cancer	2.4e-05	0.000111	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SMAD4—stomach cancer	2.39e-05	0.00011	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAPK1—stomach cancer	2.38e-05	0.00011	CbGpPWpGaD
Raloxifene—AOX1—Disease—EGFR—stomach cancer	2.38e-05	0.00011	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HBEGF—stomach cancer	2.37e-05	0.000109	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.36e-05	0.000109	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CA1—stomach cancer	2.36e-05	0.000109	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CKB—stomach cancer	2.36e-05	0.000109	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FBP1—stomach cancer	2.36e-05	0.000109	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCL8—stomach cancer	2.36e-05	0.000109	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCL8—stomach cancer	2.35e-05	0.000108	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGFR2—stomach cancer	2.33e-05	0.000107	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MTHFR—stomach cancer	2.28e-05	0.000105	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FYN—stomach cancer	2.27e-05	0.000104	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.25e-05	0.000104	CbGpPWpGaD
Raloxifene—AOX1—Disease—KRAS—stomach cancer	2.25e-05	0.000104	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLIN2—stomach cancer	2.22e-05	0.000102	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTT1—stomach cancer	2.2e-05	0.000101	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRB2—stomach cancer	2.18e-05	0.000101	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2A6—stomach cancer	2.17e-05	0.0001	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CA2—stomach cancer	2.16e-05	9.96e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CD44—stomach cancer	2.16e-05	9.95e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCL8—stomach cancer	2.14e-05	9.88e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PPP2R1A—stomach cancer	2.14e-05	9.86e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IRS2—stomach cancer	2.13e-05	9.83e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PPARG—stomach cancer	2.13e-05	9.8e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGFR2—stomach cancer	2.13e-05	9.8e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKR1C3—stomach cancer	2.12e-05	9.75e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NT5E—stomach cancer	2.11e-05	9.71e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PGAM1—stomach cancer	2.11e-05	9.71e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CAV1—stomach cancer	2.1e-05	9.68e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—APOA1—stomach cancer	2.1e-05	9.66e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CAV1—stomach cancer	2.07e-05	9.53e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—PIK3CA—stomach cancer	2.06e-05	9.51e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APOA1—stomach cancer	2.06e-05	9.51e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ENO1—stomach cancer	2.06e-05	9.5e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.03e-05	9.34e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLCE1—stomach cancer	2.01e-05	9.26e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.01e-05	9.26e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.01e-05	9.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SMAD4—stomach cancer	1.99e-05	9.16e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PRKCB—stomach cancer	1.97e-05	9.07e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6ST—stomach cancer	1.96e-05	9.04e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS2—stomach cancer	1.95e-05	8.97e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—UMPS—stomach cancer	1.93e-05	8.88e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SERPINE1—stomach cancer	1.92e-05	8.83e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—HRAS—stomach cancer	1.91e-05	8.8e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CAV1—stomach cancer	1.89e-05	8.7e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FYN—stomach cancer	1.89e-05	8.7e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APC—stomach cancer	1.88e-05	8.68e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOA1—stomach cancer	1.88e-05	8.68e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PPARG—stomach cancer	1.85e-05	8.51e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPP2R1A—stomach cancer	1.84e-05	8.46e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CD44—stomach cancer	1.83e-05	8.43e-05	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—stomach cancer	1.83e-05	8.42e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MAPK3—stomach cancer	1.8e-05	8.32e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTP1—stomach cancer	1.8e-05	8.3e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PRKCB—stomach cancer	1.8e-05	8.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PDHA1—stomach cancer	1.79e-05	8.25e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ECHS1—stomach cancer	1.79e-05	8.25e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6ST—stomach cancer	1.79e-05	8.25e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMOX1—stomach cancer	1.78e-05	8.19e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.77e-05	8.17e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGFR2—stomach cancer	1.77e-05	8.16e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6R—stomach cancer	1.75e-05	8.06e-05	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CA—stomach cancer	1.73e-05	7.97e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APC—stomach cancer	1.72e-05	7.93e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MAPK1—stomach cancer	1.72e-05	7.91e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—stomach cancer	1.72e-05	7.91e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TYMP—stomach cancer	1.68e-05	7.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FADS1—stomach cancer	1.68e-05	7.76e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TYMS—stomach cancer	1.67e-05	7.72e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ALB—stomach cancer	1.66e-05	7.65e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTM1—stomach cancer	1.66e-05	7.63e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MAPK3—stomach cancer	1.65e-05	7.59e-05	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CA—stomach cancer	1.64e-05	7.56e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SERPINE1—stomach cancer	1.64e-05	7.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS2—stomach cancer	1.62e-05	7.48e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—KRAS—stomach cancer	1.62e-05	7.47e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6R—stomach cancer	1.6e-05	7.36e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NOS3—stomach cancer	1.59e-05	7.32e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RHOA—stomach cancer	1.58e-05	7.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SREBF2—stomach cancer	1.58e-05	7.27e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CAV1—stomach cancer	1.57e-05	7.25e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOA1—stomach cancer	1.57e-05	7.23e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MAPK1—stomach cancer	1.57e-05	7.22e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—stomach cancer	1.57e-05	7.22e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOS3—stomach cancer	1.56e-05	7.21e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—RORA—stomach cancer	1.56e-05	7.18e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ERCC2—stomach cancer	1.56e-05	7.17e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPP2R1A—stomach cancer	1.55e-05	7.16e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTP1—stomach cancer	1.52e-05	7.03e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMOX1—stomach cancer	1.5e-05	6.93e-05	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CA—stomach cancer	1.5e-05	6.9e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRKCB—stomach cancer	1.5e-05	6.9e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SERPINE1—stomach cancer	1.5e-05	6.89e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6ST—stomach cancer	1.49e-05	6.87e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CA—stomach cancer	1.49e-05	6.87e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—KRAS—stomach cancer	1.48e-05	6.82e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ERBB2—stomach cancer	1.46e-05	6.74e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—stomach cancer	1.46e-05	6.74e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALDOB—stomach cancer	1.46e-05	6.73e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—stomach cancer	1.45e-05	6.7e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RHOA—stomach cancer	1.44e-05	6.65e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APC—stomach cancer	1.43e-05	6.6e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOS3—stomach cancer	1.43e-05	6.58e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TYMS—stomach cancer	1.42e-05	6.53e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTM1—stomach cancer	1.4e-05	6.46e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCL8—stomach cancer	1.39e-05	6.39e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HRAS—stomach cancer	1.38e-05	6.35e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CA—stomach cancer	1.36e-05	6.27e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALOX5—stomach cancer	1.36e-05	6.26e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CDKN1B—stomach cancer	1.35e-05	6.24e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CAV1—stomach cancer	1.35e-05	6.22e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOA1—stomach cancer	1.35e-05	6.2e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—DPYD—stomach cancer	1.34e-05	6.15e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ERBB2—stomach cancer	1.34e-05	6.15e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6R—stomach cancer	1.33e-05	6.13e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—stomach cancer	1.32e-05	6.08e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ERCC2—stomach cancer	1.32e-05	6.07e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCND1—stomach cancer	1.29e-05	5.96e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—JUN—stomach cancer	1.29e-05	5.94e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCL8—stomach cancer	1.27e-05	5.84e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HRAS—stomach cancer	1.26e-05	5.8e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MMP9—stomach cancer	1.25e-05	5.78e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CDKN1A—stomach cancer	1.25e-05	5.76e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MAPK3—stomach cancer	1.25e-05	5.74e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SERPINE1—stomach cancer	1.25e-05	5.74e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—stomach cancer	1.24e-05	5.71e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDKN1B—stomach cancer	1.24e-05	5.7e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK8—stomach cancer	1.22e-05	5.62e-05	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—stomach cancer	1.21e-05	5.59e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—stomach cancer	1.2e-05	5.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RHOA—stomach cancer	1.2e-05	5.54e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOS3—stomach cancer	1.19e-05	5.48e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PPARG—stomach cancer	1.19e-05	5.47e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTT1—stomach cancer	1.18e-05	5.44e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCND1—stomach cancer	1.18e-05	5.44e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—JUN—stomach cancer	1.18e-05	5.43e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.17e-05	5.38e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MMP9—stomach cancer	1.15e-05	5.28e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CAV1—stomach cancer	1.14e-05	5.26e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CDKN1A—stomach cancer	1.14e-05	5.26e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOA1—stomach cancer	1.14e-05	5.25e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.14e-05	5.23e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—stomach cancer	1.13e-05	5.19e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT3—stomach cancer	1.12e-05	5.14e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK8—stomach cancer	1.11e-05	5.13e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ERBB2—stomach cancer	1.11e-05	5.13e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ENO1—stomach cancer	1.11e-05	5.1e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.09e-05	5.03e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ALB—stomach cancer	1.07e-05	4.92e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK3—stomach cancer	1.07e-05	4.91e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCL8—stomach cancer	1.05e-05	4.86e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—stomach cancer	1.04e-05	4.78e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN1B—stomach cancer	1.03e-05	4.75e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—stomach cancer	1.03e-05	4.74e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NOS3—stomach cancer	1.02e-05	4.7e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT3—stomach cancer	1.02e-05	4.69e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK1—stomach cancer	1.01e-05	4.67e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—stomach cancer	1.01e-05	4.67e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PPARG—stomach cancer	1e-05	4.63e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCND1—stomach cancer	9.83e-06	4.53e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CD44—stomach cancer	9.81e-06	4.52e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—JUN—stomach cancer	9.81e-06	4.52e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK3—stomach cancer	9.73e-06	4.48e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KRAS—stomach cancer	9.58e-06	4.41e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MMP9—stomach cancer	9.54e-06	4.4e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CDKN1A—stomach cancer	9.51e-06	4.38e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—stomach cancer	9.46e-06	4.36e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—stomach cancer	9.33e-06	4.3e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK8—stomach cancer	9.28e-06	4.28e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK1—stomach cancer	9.26e-06	4.27e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—stomach cancer	9.26e-06	4.27e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ALB—stomach cancer	9.03e-06	4.16e-05	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CA—stomach cancer	8.94e-06	4.12e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CA—stomach cancer	8.8e-06	4.06e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KRAS—stomach cancer	8.74e-06	4.03e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NOS3—stomach cancer	8.64e-06	3.98e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—stomach cancer	8.57e-06	3.95e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—stomach cancer	8.51e-06	3.92e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT3—stomach cancer	8.48e-06	3.91e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.34e-06	3.85e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTP1—stomach cancer	8.18e-06	3.77e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HRAS—stomach cancer	8.14e-06	3.75e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK3—stomach cancer	8.1e-06	3.74e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMOX1—stomach cancer	8.07e-06	3.72e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	8.03e-06	3.7e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—stomach cancer	7.9e-06	3.64e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—stomach cancer	7.88e-06	3.63e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—stomach cancer	7.79e-06	3.59e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—stomach cancer	7.77e-06	3.58e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK1—stomach cancer	7.71e-06	3.55e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—stomach cancer	7.71e-06	3.55e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TYMS—stomach cancer	7.61e-06	3.51e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTM1—stomach cancer	7.52e-06	3.47e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HRAS—stomach cancer	7.43e-06	3.43e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KRAS—stomach cancer	7.28e-06	3.36e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—stomach cancer	7.11e-06	3.28e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ERCC2—stomach cancer	7.07e-06	3.26e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CA—stomach cancer	6.69e-06	3.08e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—stomach cancer	6.65e-06	3.06e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—stomach cancer	6.47e-06	2.98e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HRAS—stomach cancer	6.19e-06	2.85e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CAV1—stomach cancer	6.13e-06	2.83e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOA1—stomach cancer	6.12e-06	2.82e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—stomach cancer	5.93e-06	2.73e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CA—stomach cancer	5.74e-06	2.65e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PPARG—stomach cancer	5.39e-06	2.48e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CA—stomach cancer	4.86e-06	2.24e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ALB—stomach cancer	4.85e-06	2.23e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NOS3—stomach cancer	4.64e-06	2.14e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—stomach cancer	4.24e-06	1.95e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.61e-06	1.2e-05	CbGpPWpGaD
